CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 85.27%
This Quarter Est. Return
1 Year Est. Return
+85.27%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.4B
AUM Growth
+$294M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
76
New
Increased
Reduced
Closed

Top Buys

1
+$42.1M
2
+$35.1M
3
+$35M
4
ASND icon
Ascendis Pharma
ASND
+$30.8M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$28.6M

Top Sells

1
+$66.8M
2
+$49.6M
3
+$37.2M
4
TECX
Tectonic Therapeutic
TECX
+$23.3M
5
TBPH icon
Theravance Biopharma
TBPH
+$22.6M

Sector Composition

1 Healthcare 97.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$97.9M 6.62%
2,590,000
+1,114,860
2
$78.8M 5.33%
1,075,000
-676,699
3
$70.6M 4.77%
600,000
+261,544
4
$70.2M 4.74%
3,600,000
-902,498
5
$67.2M 4.54%
920,000
-185,557
6
$56.6M 3.83%
1,100,000
+450,000
7
$52.6M 3.55%
615,000
-59,251
8
$48M 3.24%
1,411,898
-62,464
9
$41.4M 2.8%
115,000
-4,069
10
$39M 2.64%
1,009,586
+277,965
11
$36M 2.43%
450,000
+88,649
12
$35.8M 2.42%
300,000
+210,000
13
$35.1M 2.37%
+2,525,900
14
$35M 2.36%
+300,000
15
$34.3M 2.32%
275,000
-175,000
16
$32.1M 2.17%
900,000
+800,000
17
$31.2M 2.11%
600,000
-77,451
18
$30.5M 2.06%
1,272,495
-13,333
19
$30.4M 2.05%
750,000
+600,000
20
$29.8M 2.02%
1,700,000
-245,659
21
$26.8M 1.81%
+850,000
22
$24.8M 1.67%
450,000
-61,395
23
$23.2M 1.57%
1,400,000
+850,000
24
$23.1M 1.56%
130,000
-12,291
25
$21.9M 1.48%
+22,000
1
2 3 4